let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
暂无分享,去创建一个
J. Lieberman | F. Yu | H. Yao | Pengcheng Zhu | Xiaoqin Zhang | Q. Pan | C. Gong | Yijun Huang | Xiaoqu Hu | F. Su | E. Song | Qiuhui Pan
[1] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[2] Mark Gerstein,et al. The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. , 2005, Developmental cell.
[3] Anindya Dutta,et al. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.
[4] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[5] AC Tose. Cell , 1993, Cell.
[6] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[7] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Rogalla,et al. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. , 1996, The American journal of pathology.
[10] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[11] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[12] F. Slack,et al. The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.
[13] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[14] Joel S Parker,et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.
[15] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[16] H. Ruohola-Baker,et al. The MicroRNA Pathway Plays a Regulatory Role in Stem Cell Division , 2006, Cell cycle.
[17] M. Clarke,et al. Cancer stem cells: models and concepts. , 2007, Annual review of medicine.
[18] Sean C. Bendall,et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro , 2007, Nature.
[19] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[20] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[21] J. Lieberman,et al. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. , 2005, Blood.
[22] B. Reinhart,et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.
[23] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] Alexander Brawanski,et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.
[25] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[26] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[27] E. Kistner,et al. Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.
[28] M. Wicha. Cancer Stem Cells and Metastasis: Lethal Seeds , 2006, Clinical Cancer Research.
[29] G. Dontu,et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.
[30] Alicia Zhou,et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.
[31] K Taira,et al. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells , 2003, Nucleic acids research.
[32] M. Al-Hajj. Cancer stem cells and oncology therapeutics , 2007, Current opinion in oncology.
[33] C. Croce,et al. miRNAs, Cancer, and Stem Cell Division , 2005, Cell.
[34] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[35] K. Wernecke,et al. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer , 2003, British Journal of Cancer.
[36] Y. Akao,et al. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.
[37] R. Schneider-Broussard,et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. , 2005, Cancer research.
[38] Y. Yen,et al. High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation. , 2005, Cancer research.
[39] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.